Laurie Barclay, MD Aug. 20, 2002
The flu vaccine is cost-effective but underused in adults, according to authors of an editorial and study published in the Aug. 15 issue of Clinical Infectious Diseases and a second study in the Aug. 20 issue of the Annals of Internal Medicine.
“If you could halve the mortality rate, would you do it?” Gregory Poland, MD, from the Mayo Clinic, asks in his editorial, citing the accompanying CID study which found that influenza vaccination of elderly patients in three large health maintenance organizations over two flu seasons reduced the mortality rate by 38% to 50%.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!